Literature DB >> 686928

Progressive dialysis encephalopathy from dialysate aluminum.

V V Rozas, F K Port, W M Rutt.   

Abstract

Progressive dialysis encephalopathy was observed as a frequent complication (eight of 34 patients) in a small hemodialysis unit. After the water used for dialysis was deionized, no further cases of encephalopathy developed in 29 patients. In the absence of other apparent changes in therapy, this significant difference in incidence (P less than .005) is considered to be the result of reduction in unusually high water aluminum levels from 0.637 mg/liter to less than 0.001 mg/liter by use of a deionizer.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 686928

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  10 in total

Review 1.  Dementia and cognitive impairment in ESRD: diagnostic and therapeutic strategies.

Authors:  Manjula Kurella Tamura; Kristine Yaffe
Journal:  Kidney Int       Date:  2010-09-22       Impact factor: 10.612

2.  What Medical Directors Need to Know about Dialysis Facility Water Management.

Authors:  Ted Kasparek; Oscar E Rodriguez
Journal:  Clin J Am Soc Nephrol       Date:  2015-05-15       Impact factor: 8.237

3.  The EEG in progressive dialysis encephalopathy: the EEG in diagnosing and screening for PDE. (Part. I).

Authors:  E Luda
Journal:  Ital J Neurol Sci       Date:  1984-12

4.  Dialysis encephalopathy, bone disease and anaemia: the aluminum intoxication syndrome during regular haemodialysis.

Authors:  I S Parkinson; M K Ward; D N Kerr
Journal:  J Clin Pathol       Date:  1981-11       Impact factor: 3.411

5.  Dialysis-associated encephalopathy: light and electron microscopic morphology and topography with evidence of aluminum by laser microprobe mass analysis.

Authors:  E Reusche; U Seydel
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

6.  Inability to produce a model of dialysis encephalopathy in the rat by aluminum administration.

Authors:  T L Perry; V W Yong; W J Godolphin; M Sutter; S Hansen; S J Kish; J G Foulks; M Ito
Journal:  Neurochem Res       Date:  1987-04       Impact factor: 3.996

Review 7.  Safety of new phosphate binders for chronic renal failure.

Authors:  Mahmoud Loghman-Adham
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

Review 8.  Metabolism and possible health effects of aluminum.

Authors:  P O Ganrot
Journal:  Environ Health Perspect       Date:  1986-03       Impact factor: 9.031

Review 9.  Lanthanum carbonate: safety data after 10 years.

Authors:  Alastair J Hutchison; Rosamund J Wilson; Svetlana Garafola; John Brian Copley
Journal:  Nephrology (Carlton)       Date:  2016-12       Impact factor: 2.506

10.  End stage renal disease is associated with development of dementia.

Authors:  Peir-Haur Hung; Chih-Ching Yeh; Chih-Yen Hsiao; Pi-Shan Sung; Chih-Hsin Muo; Fung-Chang Sung; Kuan-Yu Hung; Kuen-Jer Tsai
Journal:  Oncotarget       Date:  2017-11-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.